Literature DB >> 18055980

Rituximab for the treatment of autoimmune cytopenias.

Sigbjørn Berentsen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18055980     DOI: 10.3324/haematol.11312

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  5 in total

1.  Long lasting remission by rituximab in a patient with primary cold agglutinin autoimmune haemolytic anaemia.

Authors:  Marjana Glaser; Andrej Glaser; Marjan Skalicky
Journal:  Wien Klin Wochenschr       Date:  2011-09-28       Impact factor: 1.704

2.  Late-onset neutropenia following rituximab treatment for rheumatologic conditions.

Authors:  Gabriel S Breuer; Michael Ehrenfeld; Itzhak Rosner; Alexandra Balbir-Gurman; Devy Zisman; Shirley Oren; Daphna Paran
Journal:  Clin Rheumatol       Date:  2014-03-06       Impact factor: 2.980

3.  Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Sung-Hoon Jung; Jae-Sook Ahn; Deok-Hwan Yang; Hyung Chul Park; Soo-Young Bae; Yeo-Kyeoung Kim; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Case Rep Oncol       Date:  2012-02-29

Review 4.  Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy.

Authors:  Sigbjørn Berentsen; Tatjana Sundic
Journal:  Biomed Res Int       Date:  2015-01-29       Impact factor: 3.411

Review 5.  New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.

Authors:  Sigbjørn Berentsen
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.